Aptevo Therapeutics (AP80.F) Q1 2025 Earnings

Feb 14Confirmed
Q4 2024
Q1 2025
-19.53
-15.48
-11.43
-7.39

Details

Expected EPS
-7.38575
Actual EPS
-8.51982
Surprise EPS
-1.13
Surprise Percent
-15.35%

Description

⁨Aptevo Therapeutics⁩ (⁦AP80.F⁩) has reported earnings of ⁦-8.51982⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts